EU Safety Gate (RAPEX) · France · 2022-01-07 · Serious risk
🌐Machine-translated with AI — the facts come from the issuing authority’s own notice (linked on this page); this language version was translated automatically by an AI model and is not reviewed. The original-language notice is authoritative. How we use AI →
Reported risk: Le pignon extérieur de l'arbre de transmission droit peut se briser en raison d'un manque de traitement thermique lors de la fabrication de la pièce, ce qui peut entraîner une rupture de l'arbre de transmission. Le moteur continuera de fonctionner, mais il n'y aura pas de transmission de couple aux roues motrices, augmentant le risque d'accident. Le produit n'est pas conforme aux exigences du règlement sur la réception et la surveillance du marché des véhicules à moteur et de leurs remorques, ainsi que des systèmes, composants et entités techniques distinctes destinés à ces véhicules.
Action taken by the authority
Type of economic operator taking notified measure
Manufacturer
Category of measure
Recall of the product from end users
Date of entry into force
29/11/2021
Machine translation. This page was translated automatically from the English record we hold of the issuing authority’s notice. The English original is shown below and the authority’s own notice is linked above — both take precedence over this translation.
Product Name (original English): 301
Risk Description (original English): The outer pinion of the right driveshaft may break due to lack of heat treatment during the manufacture of the part which may lead to a break in the transmission shaft. The engine will still run, but there is no torque transmission to the drive wheels, increasing the risk of accident.
Verify each fact at the issuing agency before acting. Recall scope, affected lots, and remediation instructions may be updated by the agency after our last sync.
ProductGuru indexes recall and safety-alert records from ~30 public agency registries. We are not lawyers, regulators or product-safety consultants. This page restates what the named agency published; consult the primary source above (or qualified counsel in your jurisdiction) before any commercial, medical or safety decision.